Are Expensive Diabetes Drugs Worth It?
The good news is that a few diabetes drugs now show valid cardioprotective benefits; the bad news is the drugs are unaffordable for many.
Obesity Is a Chronic Disease, Say New Guidelines
The new evidence-based, comprehensive recommendations replace 2012's "piecemeal" effort to guide clinical management.
Women, Older Patients More Likely to Visit Doc Because of Obesity
The annual visit rate to a physician for obesity in 2012 was 49 per 1000 people, according to the latest CDC report.
Weight Loss Programs Seem to Lag Behind Treatment Guidelines
Surveys show that up to 48% of Americans are actively trying to lose weight. New research finds reliable support in short supply.
Big Health Payoffs for Cutting Sugar in Beverages
British modelling study calculates significant drops in overweight, obesity, and obesity-related diabetes via reducing sugar in beverages alone.
Diabetes: Mulling Jardiance Heart Benefit
The empagliflozin CV benefit was "astounding" and a first for any diabetes drug, but what does it actually mean?
Obese Patients Unlikely to Return to Normal Weight
New study findings are grim, suggesting that fewer than 1% of the obese who work at weight loss will have sustained success.
A Nutty Way to Prevent Cancer?
A large review ties nut consumption to a lower incidence of cancer, but not diabetes.
The Skinny on Dementia and Being Skinny
Underweight means highest risk, say researchers.
Citing Risks, FDA Calls for Label Changes to T Therapy
The FDA will require labels on prescription testosterone products that disclose a possible increased risk of heart attacks and strokes. A “black box” warning won’t be added.
